Analysis of circulating tumour DNA for early detection and selection of cancer patients for precision medicine Job description You will join a team that focuses on the study of circulating tumor DNA (and RNA) for the diagnosis of cancer and therapeutic stratification for precision medicine (“liquid” biopsy). The development of these liquid biopsies is based on Massively Parallel Sequencing (Next Generation Sequencing) of circulating tumor DNA (and RNA) present in plasma of cancer patients. We will use Shallow Whole Genome Sequencing (for the detection of Copy Number Alterations), as well as targeted sequencing (for the detection of point mutations in many oncogenes, tumor suppressor genes and DNA repair genes). Your task in the team focuses on the development of bioinformatic and statistical tools for the analysis of the Next Generation Sequencing data. Furthermore, you will be intensely involved in the selection of genes for large panels relevant for the development of liquid biopsies. The aim of the project is early diagnosis of cancer, therapeutic stratification for precision medicine, follow-up after therapy, and the detection of potential targets for therapy. The project focuses on lung cancer and lymphoma, but the approach is also promising for other tumor types. The project is a collaboration between the Department of Pathology (Laboratory for Cancer Diagnostics and Pathology), the Center for Medical Genetics, the Department of Thoracic Oncology, the Department of Hematology, and the Center for Molecular Diagnostics Ghent. All these clinical departments and laboratories are located at the campus of Ghent University Hospital. Profile of the candidate ● You hold a master degree in one of the following disciplines: Bioengineering, Biochemistry and Biotechnology, Bioinformatics or an equivalent field. ● You are interested in challenging scientific research. ● You are interested in cancer biology and molecular biological techniques. In close collaboration with the other team members you will try to gain insight in the genetic alterations in tumors, important for the development of diagnostic and prognostic molecular tests on circulating tumor DNA (and RNA). ● You aim is to obtain a PhD degree. ● You have knowledge of bioinformatic tools and in particular of genomics data analysis (e.g. Whole Exome Sequencing, Whole Genome Sequencing, …). ● You have knowledge of commonly used programming languages in bioinformatics, like R, Python and Perl. ● You can work independently, but are also a good team player. ● You are a creative mind and a problem solver. ● You are communicative. ● You hold, or expect to hold by June 2017, a master degree (the latest starting date is August 1, 2017). How to apply? Interested? We are looking forward to receiving your C.V., together with an overview of your study results, a motivation letter and two references. Send your application to katrien.vanbost@ugent.be<mailto:katrien.vanbost@ugent.be>. For more information, please contact: Prof. dr. Jo Van Dorpe Department of Pathology - Laboratory for Cancer Diagnostics and Pathology jo.vandorpe@uzgent.be<mailto:jo.vandorpe@uzgent.be> T +32 9 332 51 38 Prof. dr. ir. Björn Menten Center for Medical Genetics Ghent bjorn.menten@ugent.be<mailto:bjorn.menten@ugent.be> T +32 9 332 52 84 Prof. dr. ir. Kathleen Claes Center for Medical Genetics Ghent kathleen.claes@ugent.be<mailto:kathleen.claes@ugent.be> T +32 9 332 24 78